Literature DB >> 17198208

Transitional medicine: will emergency medicine physicians be ready for the growing population of adults with congenital heart disease?

Keith P Cross1, Karen A Santucci.   

Abstract

BACKGROUND: Currently, approximately 85% of children with significant congenital heart problems survive to adolescence and adulthood. This survival rate represents a dramatic improvement in the medical and surgical care of congenital heart disease (CHD) during the last 35 years. Nevertheless, these patients remain at increased risk for significant cardiac problems long after primary interventions are completed. They are more likely than the general population to seek urgent medical care, often in an emergency department setting. They represent a new and growing population of emergency department patients with a specialized set of problems not traditionally part of the training for emergency medicine (EM) physicians.
OBJECTIVE: We investigated the current scope and status of training for EM physicians in the immediate management of CHD patients as they grow to adolescence and adulthood.
METHODS: We conducted 2 cross-sectional surveys to assess the current training environment for 2 specific groups: (1) US general EM (GEM) residency programs, and (2) US and Canadian pediatric EM (PEM) fellowship programs. Surveys were mailed to program directors during the summer of 2005. A total of 198 surveys were sent out: 134 to GEM residency directors and 64 to PEM fellowship directors.
RESULTS: The response rate overall was 68%, with a 64% response rate from the GEM residency directors and 77% from the PEM fellowship directors. Across all programs, 43% (56/130 respondents) were "unsure" about the existence or location of an adult CHD (ACHD) clinic in their area. When asked to rate the importance of ACHD as a training topic, 40 (85%) of 47 PEM fellowship directors and 62 (74%) of 84 GEM residency directors ranked it as "low priority" or "unnecessary." However, 70 (55%) of 127 respondents were "unsure," "uncomfortable," or "worried" about the ACHD training their trainees receive (PEM, 59%; GEM, 53%). In addition, most program directors (75%) estimated that their trainees care for 5 or fewer ACHD patients annually.
CONCLUSIONS: There seems to be a mismatch between the growing need for ACHD emergency care and the current state of this topic in both GEM residency and PEM fellowship training programs.

Entities:  

Mesh:

Year:  2006        PMID: 17198208     DOI: 10.1097/01.pec.0000245178.13418.4f

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  4 in total

Review 1.  Pediatric emergency medicine point-of-care ultrasound: summary of the evidence.

Authors:  Jennifer R Marin; Alyssa M Abo; Alexander C Arroyo; Stephanie J Doniger; Jason W Fischer; Rachel Rempell; Brandi Gary; James F Holmes; David O Kessler; Samuel H F Lam; Marla C Levine; Jason A Levy; Alice Murray; Lorraine Ng; Vicki E Noble; Daniela Ramirez-Schrempp; David C Riley; Turandot Saul; Vaishali Shah; Adam B Sivitz; Ee Tein Tay; David Teng; Lindsey Chaudoin; James W Tsung; Rebecca L Vieira; Yaffa M Vitberg; Resa E Lewiss
Journal:  Crit Ultrasound J       Date:  2016-11-03

2.  Transition in Patients with Congenital Heart Disease in Germany: Results of a Nationwide Patient Survey.

Authors:  Paul C Helm; Harald Kaemmerer; Günter Breithardt; Elisabeth J Sticker; Roland Keuchen; Rhoia Neidenbach; Gerhard-Paul Diller; Oktay Tutarel; Ulrike M M Bauer
Journal:  Front Pediatr       Date:  2017-05-19       Impact factor: 3.418

3.  Mixed-methods approach to understanding clinician macrocognition in the design of a clinical decision support tool: a study protocol.

Authors:  Azadeh Assadi; Peter Laussen; Patricia Trbovich
Journal:  BMJ Open       Date:  2020-03-25       Impact factor: 2.692

Review 4.  [Adults with congenital heart disease presenting to the emergency department : Potential pitfalls].

Authors:  J Mair; G-P Diller; H Geiger; M Greutmann; G Hessling; D Tobler
Journal:  Med Klin Intensivmed Notfmed       Date:  2020-10-25       Impact factor: 0.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.